Another study found that mesenchymal stem cell-derived exosomal miRNA-133b suppressed glioma progression via the Wnt/β-catenin signaling pathway by targeting EZH2 (Xu et al., 2019). The gene discussed is EZH2; the disease is central nervous system cancer.